Search results
Added:
1 year ago
AF Symposium 25 - Left atrial appendage (LAA) closure using the WATCHMAN FLX device (Boston Scientific) showed lower risk of bleeding and non-inferiority in efficacy endpoints to oral anticoagulation in patients who have received or are planning to receive AF ablation.Dr Walid Saliba (Cleveland Clinic, OH, US) joins us onsite at AF Symposium 25 to discuss the findings from the concomitant and…
View more
Added:
2 weeks ago
HRS Congress 2026 — Dr Jonathan Piccini (Duke Health, Durham, NC, US) and Dr Jared Bunch (University of Utah, Salt Lake City, UT, US) join forces for a timely discussion on one of the most consequential questions facing electrophysiologists today: whether anticoagulation can be safely discontinued in patients following successful atrial fibrillation ablation.Recorded on-site at HRS Congress 2026,…
View more
Added:
1 month ago
HRS Congress 2026 — Prof Ulrich Schotten (Maastricht University, Maastricht, NL) joins us to discuss new findings from the NOAH-AFNET 6 trial examining the distribution of atrial fibrillation burden, its relationship to clinical outcomes, and the effectiveness and safety of anticoagulation based on device reports.NOAH-AFNET 6 (Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial…
View more
AHA 25: The OCEAN Trial
Added:
6 months ago
Video
Added:
2 years ago
EHRA 24 - We are joined onsite by Dr Julius Nikorowitsch (University Heart and Vascular Centre Hamburg (UHZ), DE) to outline the impact of age, sex, cardiovascular comorbidities, and kidney function on outcomes with oral anticoagulation therapy in patients with device-detected atrial fibrillation in a substudy of the NOAH-AFNET 6 trial (NCT02618577).The substudy consisted of 2534 patients from…
View more
Added:
1 month ago
HRS Congress 2026 — Dr Robert Schaller (Penn Medicine, US) presents results from the ASCEND CSP IDE Study, evaluating the safety and effectiveness of a novel stylet-driven ICD lead designed specifically for left bundle branch area pacing — a step toward establishing CSP as a viable platform for patients requiring both defibrillation therapy and physiological pacing.This prospective, multicentre,…
View more
Added:
9 months ago
Presented at the European Society of Cardiology (ESC) Congress 2025, Prof Carolyn Lam (Singapore, UK), Prof Davide Capodanno (Catania, IT), Dr Sneha Shah Jain (Stanford, US) and Prof Jeffrey Weitz (Hamilton, CA) examine the prevalence and challenges of stroke prevention in atrial fibrillation (AF) and after acute coronary syndrome (ACS). The faculty review current treatment guidelines, explore…
View more
Added:
2 years ago
EHRA 24 - We interview Dr Vivek Reddy (Icahn School of Medicine at Mount Sinai, US) on a first-in-human clinical trial of a novel conformable "single-shot" pulsed field ablation (PFA) catheter for pulmonary vein isolation (PVI).This single arm trial aimed to assess the safety and efficacy of PVI using an 8Fr PFA catheter (SpherePVI, Affera Inc) in 30 patients across three centers.Interview…
View more
Hakan Oral
Research Area(s) / Expertise:
Author
Aortic Atherosclerosis as a Predictor of LAA Thrombus
Added:
9 months ago
Original Research